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Background: Chronic fatigue syndrome (CFS) has no diagnostic clinical signs or biomarkers, so diagnosis requires
ruling out conditions with similar signs and symptoms. We conducted a pilot registry of unexplained fatiguing
illnesses and CFS to determine the feasibility of establishing and operating a registry and implementing an
education outreach initiative. The pilot registry was conducted in Bibb County, Georgia. Patient referrals were
obtained from healthcare providers who were identified by using various education outreach initiatives. These
referrals were later supplemented with self-referrals by members of a local CFS support group. All patients meeting
referral criteria were invited to participate in a screening interview to determine eligibility. If patients met registry
criteria, they were invited to a one-day clinic for physical and laboratory evaluations. We classified patients based on
the 1994 case definition.
Results: We registered 827 healthcare providers. Forty-two providers referred 88 patients, and 58 patients (66%)
completed clinical evaluation. Of the 188 CFS support group members, 53 were self-referred and 46 (87%)
completed the clinical evaluation. Of the 104 participants completing evaluation, 36% (n = 37) met the criteria for
CFS, 17% (n = 18) had insufficient fatigue or symptoms (ISF), and 47% (n = 49) were found to have exclusionary
medical or psychiatric illnesses. Classification varied significantly by type of referral but not by previous history of
CFS diagnosis. Healthcare providers referred more patients who were classified as CFS as compared to support
group referrals in which more exclusionary conditions were identified. Family practice and internal medicine
specialties made the most referrals and had the highest number of CFS cases. We conducted three CME events,
held three “Meet and Greet” sessions, visited four large clinical health practices and health departments, mailed five
registry newsletters, and conducted in-person office visits as part of education outreach, which contributed to
patient referrals.
Conclusions: Referrals from healthcare providers and self-referrals from the patient support group were important
to registry enrollment. The number of potentially treatable conditions that were identified highlights the need for
continued medical management in this population, as well as the limitations of registries formed without clinical
examination. Education initiatives were successful in part because of partnerships with local organizations.
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Chronic fatigue syndrome (CFS) is a debilitating condition
that affects over 1 million adults in the United States with
many more experiencing chronic symptoms of fatigue
[1-4]. A CFS diagnosis is based on self-reported chronic
symptoms, unexplained severe fatigue present for six
months or more, and at least four of eight other symptoms
(impaired memory or concentration, muscle pain, pain in
multiple joints, unrefreshing sleep, tender lymph nodes,
sore throat, headaches, post-exertional malaise) that are
severe enough to significantly interfere with the perform-
ance of daily activities and work [5]. Diagnosis of CFS re-
quires ruling out concurrent medical and psychiatric
conditions with similar clinical signs and symptoms. CFS
has no diagnostic biomarkers, signs, or laboratory tests,
and despite over two decades of research, the etiology and
pathophysiology are yet to be determined.
The lack of objective diagnostic criteria poses a chal-
lenge for physicians and helps explain the low diagnostic
confidence [6]. In spite of this, most physicians (94%)
are aware of CFS, and 40% report having diagnosed the
illness [7]. This high level of provider awareness belies
estimates that fewer than 20% of people with CFS have
been diagnosed [8].
CFS patient registries can provide information con-
cerning the nature of the illness among those receiving
medical care. Twin registries and the Gulf War Registry
have been used to study CFS prevalence, the medical im-
pact of illness, and the role of environmental and genetic
factors [9-13]. However, published twin registries have not
medically evaluated participants. They use questionnaires
to assess and classify fatigue and CFS often in conjunction
with reported physician diagnosis [12,13]. Registries, such
as the United Kingdom pilot CFS/ME registry, also pro-
vide a cost effective means of evaluating aspects of CFS,
identifying CFS for clinical studies, and evaluating clinical
course [14]. In conjunction with population-based CFS
surveillance, registries provide a means of exploring fac-
tors associated with health care use by people with CFS.
This report concerns the feasibility of establishing and
operating a pilot registry that was conducted in Bibb
County, Georgia. The objectives of this registry were
1) to recruit and register medical and ancillary health-
care providers in and around Bibb County, 2) to encour-
age enrolled healthcare providers to refer patients with
unexplained fatiguing illnesses and CFS, 3) to clinically
evaluate referred patients, and 4) to implement an edu-
cation outreach initiative. The registry was later sup-
plemented by local support group members through
self-referral. We clinically evaluated all referred patients
according to the protocol used in population surveil-
lance so as to diagnose CFS by international criteria [5],
identify exclusionary medical and psychiatric conditions,
and collect sociodemographic and related information.Methods
The pilot registry was conducted in Bibb County,
Georgia from September 2008 to March 2010. This pilot
included a six-month healthcare provider recruitment
phase followed by a full year of patient referrals to a re-
search clinic, where patients were clinically evaluated
[1]. A needs assessment in the form of focus groups with
Bibb County healthcare providers was conducted before
the registry, and these results helped to inform the regis-
try study design. For example, time commitments and
burden on support staff were identified as concerns,
whereas a benefit was the desire to receive updates
throughout the study period. In December 2009 the
Registry expanded to allow members of the local CFS
support group to self-refer to the registry. This study ad-
hered to U.S. Department of Health and Human Ser-
vices policies for the protection of human research
subjects and was approved by the CDC Institutional Re-
view Board. All participants gave informed consent. The
registry methods are reported in five parts: Healthcare
Provider Recruitment, Healthcare Provider Enrollment
and Referrals, Support Group Referral, Referrals for
Clinical Evaluation, and Registry Education Initiatives.
Healthcare provider recruitment
Healthcare providers included traditional medical pro-
viders (e.g., physicians and nurse practitioners) as well as
complementary and alternative medical providers (e.g.,
acupuncturists and physical therapists) (see Additional
file 1: Table S1 for a full list of healthcare provider
categories by physicians and non-physicians). We identi-
fied healthcare providers in and around Bibb County,
Georgia through data obtained from insurance websites,
a purchased external vendor list, the Georgia State Board
of Medical Examiners, Internet searches of local medical
practices, and from a local support group.
We aimed to recruit 600 healthcare providers who
would in turn refer patients for registry enrollment and
clinical evaluation. Eligibility criteria for healthcare pro-
viders included: currently practicing in Bibb County or
within a 30-mile radius of Bibb County, and willingness
to assess patients for registry inclusion/exclusion criteria.
Exclusion criteria for healthcare providers included prac-
ticing exclusively in a nursing home, Veteran’s Affairs
(VA) hospital, mental health hospital, military or correc-
tional facility; being retired or deceased; and not cur-
rently treating or diagnosing patients.
In early August 2008, we sent a one-page flier announ-
cing the registry to the 1,787 identified healthcare pro-
viders and invited them to attend a CDC-sponsored CFS
continuing medical education (CME) course. In early
September 2008, a Registry Kick-Off packet was sent to
all identified providers, which included a registry intro-
duction letter, registry fact sheet, and an enrollment
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included the incentive of a $1 bill to increase attention
and awareness. In December 2008, a local Georgia-based
firm was contracted to actively recruit and register pro-
viders by calling and visiting offices and track provider
recruitment and enrollment status. This firm added a
proprietary marketing list to the database for a final
master list of 2,190 healthcare providers. Provider re-
cruitment outcomes were classified as verified eligible
(eligible providers who were enrolled in the registry); in-
eligible (providers who did not meet inclusion criteria);
refused (providers who refused to participate); unlocatable
(providers who could not be reached at listed contact
information); and nonresponse (providers who were not
reached within 5 telephone contacts).
Healthcare provider enrollment and referrals
Healthcare providers were sent a Provider Verification
Form for assessment of inclusion and exclusion criteria;
providers were requested to return the form by fax, mail
with pre-paid envelope, phone call to the toll-free regis-
try number, or use of the registry website. Once pro-
viders were registered, they were sent a Provider Packet
and Patient Referral Packets. The Provider Packet con-
tained a letter with a unique provider code; login andTable 1 Registry referral inclusion and exclusion criteria
Inclusion referral criteria* E





e• Unexplained severe fatigue persisting for one month or longer.
• One of the following for at least one month:
o unrefreshing sleep, •
o problems with memory or concentration, or •
o unexplained joint or muscle pain. •
• A body mass index of less than 40.0 •
f
• Age 12 to 59 (However, in November 2009, CDC expanded the eligible
age range to 69 years of age. This upper age range limit was clarified to
mean that in order to be eligible, the subject must be no more than 69














*The registry inclusion/exclusion referral criteria are not for CFS classification.password for the registry website, a provider referral
form; registry referral criteria (Table 1); a questionnaire
for measuring knowledge, attitudes, and beliefs about
CFS; and a fact sheet of responses to frequently asked
questions. The provider was instructed to give the Pa-
tient Referral Packet to eligible patients. The Patient Re-
ferral Packet contained a letter for the adult or parents
of adolescent participants, a permission-to-be-contacted
form, and a fact sheet about the registry and questions
frequently asked by patients.
In making a referral, healthcare providers assessed pa-
tients only for registry referral criteria; not for chronic fa-
tigue syndrome. Inclusion criteria for patients consisted of
medically unexplained, severe fatigue persisting for one
month or longer and at least one month’s duration of
sleep, or problems with memory or concentration, or un-
explained joint or muscle pain; a body mass index less
than 40; and age 12–69 as of September 15, 2009 (Table 1).
Exclusion criteria noted in Table 1 are consistent with the
1994 CFS case definition [5] (Table 1). Registry referral
criteria were deliberately relaxed to capture patients who
would be further assessed for CFS later during clinical
evaluation at the registry clinic. Because a differential diag-
nosis of fatigue can take months, providers did not have to
conduct a full workup of CFS. Instead, physicians werexclusion referral criteria*
roviders were instructed to rule out other potential causes of fatigue by
onducting laboratory tests and medical history or medical histories
lone before referring their patients. The registry had the following
xclusion criteria:
Pregnancy within past 12 months
Stroke with no full recovery
Parkinson’s disease
Chronic obstructive pulmonary disease (COPD) or congestive heart
ailure
Insulin-dependent diabetes
Uncontrolled diabetes type II (HgbA1c < 9%)
Anemia
Uncontrolled hypo- or hyper-thyroidism
Uncontrolled hypertension (BP > 140/90)
Sickle cell anemia
Cancer within 5 years (except basal skin) or current chemotherapy
Untreated depression
Substance abuse problems within the past 2 years
Anorexia nervosa or bulimia nervosa within the past 5 years
Schizophrenia, bipolar I or II disorder, or dementia
Hepatitis B or C
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history, and non-physicians were required to take a med-
ical history.
Registered health care providers filled out the provider
referral form and asked their patients to fill out the “per-
mission-to-be-contacted form” if they were interested
in participating in the registry. Patients could not be
contacted by registry staff if the completed permission
form was not received, even if the provider had submit-
ted the provider referral form. When this situation oc-
curred, a two-week follow-up courtesy call was made to
the referring provider to notify him or her about the
missing permission form from the patient, with the hope
that the provider would remind the patient. Patients
who never submitted their permission forms were ultim-
ately coded as nonresponders. Providers were instructed
to return their completed referral forms by fax, mail, toll
free number, or the registry website. Patients could re-
turn permission-to-be-contacted forms by fax, mail, or
toll free number.
We used several strategies to encourage healthcare
providers to refer patients. Registry staff made in-person
visits to large medical practices (those with at least 10
providers at a single site) and to providers who had been
registered for at least three months without making any
referrals. Visits to large medical practices included lunch
and a brief presentation on the registry referral criteria
and process; visits to individual providers included dis-
tribution of extra materials and in some cases, an appre-
ciation gift of either M&Ms or a pen. Additionally,
providers were sent a thank you note upon the referral
of each patient.
Support group referral
CDC partnered with a local support group early in the
registry to apprise them of the registry’s research objec-
tives, although referrals from support group members
were not solicited in the first year of patient enrollment.
The local support group was founded in 1990 and has
met once a month since its inception; it serves as a safe
place for people to talk about their illness and gain ac-
ceptance as well as obtain educational information.
Membership has no requirements; however, most mem-
bers have been diagnosed with CFS or fibromyalgia. In
October 2009, with the backing of the support group
leader, we gave a more in-depth presentation of the
registry goals and invited support group members to
refer themselves to the registry staff. Support group
members (n = 188) were sent packets that included an
instruction letter describing how to contact the registry,
inclusion and exclusion criteria (Table 1), frequently
asked questions, and a body mass index (BMI) table for
determining whether their BMI exceeded the inclusion-
ary range. Support group members were expected toreview the inclusion and exclusion criteria and deter-
mine whether they met criteria for self-referral; if so,
members could refer themselves to the registry by using
the toll free number.
Referrals for clinical evaluation
Upon receipt of the permission-to-be-contacted form
(provider-referred patients) or the self-referral phone call
(support group members), registry staff contacted pro-
spective registry patients for a screening interview. The
screening interview was conducted by using a computer-
assisted telephone interview (CATI) from September
2008 through November 2009. CDC physicians and
study personnel reviewed all CATI data and determined
final clinical eligibility. Patients meeting screening cri-
teria were then contacted to arrange an appointment for
their clinical evaluation. Given the high eligibility rate,
we converted the CATI to a computer-assisted personal
interview (CAPI) in December 2009. The CAPI screen-
ing questions were identical to items on the CATI, but
CAPI was interviewer-administered onsite in the registry
clinic. Patients who did not complete the CATI received
a short screening call before clinic scheduling to deter-
mine fatigue and symptom eligibility status.
All patients (provider- and self-referred) were evalu-
ated by the same registry referral inclusion and exclusion
criteria. For example, for patients who responded during
screening that they experienced fatigue that lasted less
than six months, a registry staff member re-contacted
the person to notify them of their temporary ineligibility
status as well to provide a date for call-back (e.g., re-
assess fatigue at the six-month mark).
Patients meeting eligibility criteria were invited to a
one-day clinical evaluation at a local research clinic and
were sent a packet of materials before the appointment
[1]. The packet included an introductory letter, sample
clinic schedule, informed consent form for review, and
registry questionnaires to complete at home. Addition-
ally, patients received materials and instructions on how
to prepare for their clinic visit, including fasting the
morning of the clinic, foregoing vitamins, herbal or nu-
tritional supplements, and homeopathic preparations for
72 hours before the clinic date, collecting and storing a
12-hour urine specimen (night before clinic visit) and
collecting waking saliva samples (morning of clinic visit).
The clinical evaluation took approximately eight hours
to complete, and patients were provided with a $450 reim-
bursement for their time. Informed consent was adminis-
tered by registry staff on the day of the appointment.
The clinical assessment included medical history, a
standardized complete physical exam, collection of urine
and blood for laboratory tests, and psychiatric evaluation
by using the Structured Clinical Interview for DSM Dis-
orders (SCID) [15]. Clinical assessment also ascertained
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dication use. To ensure uniform practice, clinic staff
(including physicians) received eight hours of instruction
on conducting a standardized clinical examination and
collecting a medical history. All clinic staff underwent a
training session to complete intake materials and adminis-
ter questionnaires. After the clinical evaluation and upon
receipt of registry clinic data, CDC physicians reviewed all
medical history questionnaires, laboratory test results, and
clinical evaluation data to determine exclusionary medical
or psychiatric conditions. Patients were classified into
three categories based on the 1994 CFS case definition [5]:
chronic fatigue syndrome (CFS); insufficient fatigue or
number of symptoms to meet the CFS definition (ISF); or
having an exclusionary condition, and therefore not quali-
fying for the 1994 Case Definition.
Registry education initiatives
An important component of the registry was to provide
medical education to registry healthcare providers and
the local healthcare community. CDC partnered with a
local medical society to raise awareness and encourage
participation in the registry. CME and “Meet and Greet”
events were co-sponsored by the local medical society
and the local university. CME events were held at the
local hospital, local registry clinic, and university out-
patient clinic. “Meet and Greet” events were held at the
local registry clinic site, and local healthcare providers
were invited to meet CDC and registry staff to learn
more about the registry. Registry newsletters were pro-
duced and mailed to enrolled healthcare providers,
which gave updates about recruitment and enrollment
numbers, had an “Ask the CDC CFS Expert” column,
cited newly published CFS journal articles, and provided
location and contact information for CME and “Meet
and Greet” events. Finally, on the basis of feedback from
the needs assessment, we developed a website, which of-
fered links for obtaining registry materials, registry
forms, and CFS educational information.
Results
Healthcare provider enrollment and referrals
Eight hundred twenty-seven healthcare providers regis-
tered for the registry, including 491 (59%) physiciansTable 2 Provider recruitment by type of provider (physician v
Verified eligible Ineligible R
n (%) n (%)
Physicians 491 (59) 147 (81)
Non-physicians 336 (41) 33 (18)
Other/Unidentifieda 0 1 (<1)
Total 827 181
aOther/Unidentified refers to providers for whom the specialty is not known, with tand 336 (41%) non-physicians for a response rate of
53% (Table 2). Fifty-five percent of the 491 enrolled
physicians were family practice/internal medicine, 11%
pediatric, and 10% obstetrics/gynecology. Of the 336
non-physicians enrolled in the registry, 39% were nurse
practitioners, 18% dentists, and 12% registered nurses.
Of registered providers, 38 had participated in needs as-
sessment focus groups. Most providers enrolled through
telephone recruitment (n = 779), followed by a second
mailing, which included $1 incentive (n = 33); initial
mailings (n = 6); provider initiated contact (n = 4); CME
events (n = 3); and the registry website (n = 2).
Forty-two enrolled healthcare providers referred 88
patients to the registry. Sixty-four percent of all referrals
came from physicians (n = 56) and 36% from non-
physician providers (n = 32). Nineteen providers referred
more than one patient, including one provider who re-
ferred nine patients. Physicians who referred patients
included family/general practitioners (n = 16), internists
(n = 15), pediatricians (n = 10), obstetrics and gynecolo-
gists (n = 9), geriatricians (n = 3), pain medicine specialists
(n = 1), and psychiatrists (n = 2). Non-physician providers
who referred patients were psychologists (n = 13), nurse
practitioners (n = 8), dentists (n = 7), an acupuncturist
(n = 1), a social worker (n = 1), a physical therapist (n = 1),
and a massage therapist (n = 1).
Healthcare providers’ preferred methods of returning
the provider referral form were fax (n = 35) or mail
(n = 33). Patients’ preferred methods included mail
(n = 38), fax (n = 24), and phone (n = 15). Although 88
patients were referred for clinical evaluation, registry
staff could only contact 78 because 10 people did not
return the permission-to-be-contacted form. Thus, 11%
of referrals were automatically excluded from potential
clinical evaluation.Support group referral
Fifty-three (28%) of 188 support group members re-
ferred themselves to the registry. Six study packets
to support group members were returned with no
forwarding address for a response rate of 29% (53/182).
Support group referrals accounted for 38% of all registry
participants.s. non-physician)
efused Unlocatable Non response Total
n (%) n (%) n (%) n (%)
59 (59) 373 (83) 99 (16) 1169 (57)
41 (41) 75 (17) 532 (84) 1017 (46)
0 1 (<1) 2 (<1) 4 (<1)
100 449 633 2190
he exception of the “other” Ineligible, who was an office manager.
Table 3 Referrals for clinical evaluation
Complete Nonresponse Refusal Ineligible Total
n (%) n (%) n (%) n (%) n (%)
Provider-referred patients 58 (56) 4b (50) 4 (80) 12c (86) 78 (60)
Support group self-referrals 46a (44) 4d (50) 1 (20) 2e (14) 53 (40)
Total 104 8 5 14 131
aOne patient signed an informed consent form agreeing to share data from the GA First Follow-up Study with the GA Registry.
bNon-contact (n = 1); moved out of area (n = 1); unlocatable (n = 2).
cIneligible baseline registry subject (n = 1); ineligible based on age (n = 2); duplicate -- referred by 2 providers (n = 1); duplicate - referred under two different
names (married and unmarried) (n = 1); Bipolar disorder reported during CATI interview (n = 2); BMI > 40 (n = 3); Rheumatoid arthritis reported during CATI
interview (n = 1); BMI > 40 and emphysema reported during CATI interview (n = 1).
dAppointment canceled, had “too much going on” (n = 1), not feeling well enough to participate (n = 2); unlocatable (n = 1).
eBMI > 40.
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Twelve (15%) of 78 patients referred by providers were
found ineligible at the time of pre-clinic screening. Only
two (4%) of 53 self-referred patients were ineligible at
pre-clinic screening (Table 3). Five people refused to
participate in the clinical evaluation and eight never
responded to the invitation for clinical evaluation. Thus,
104 of 131 referred patients completed clinical evalu-
ation for a 79% response rate. (See Additional file 2:
Figure S1 for a flow chart of provider recruitment and
patient enrollment).
Registry education and outreach initiatives
Over the pilot registry time period, we held three local
CME events, sponsored three “Meet and Greet” sessions,
published and distributed five newsletters to all 827 en-
rolled providers and maintained the registry website.
Ninety-six people received CME credits and 25 providers
attended the “Meet and Greet” sessions. The registry web-
site received more than 1700 visits, 87% (n = 1517) from
within the United States. Only two providers registered
through the website, and no providers referred patients
through the site. Outreach visits to healthcare providers
were conducted to stimulate participation in the registry.
Visits were made to 19% (n = 157) of enrolled providers;Table 4 Impact of education and outreach activities on referr
Activity # of providers
n (%)
Focus group 2 (5)
CMEa 3 (7)
Meet and greet 3 (7)
Incentive visit 4 (10)
Visit only 13 (31)
Two activities 1 (2)
No contact 16 (38)
Total 42
aContinuing medical education.
1Note: 36 (5%) of the 785 enrolled providers who did not make any referrals partici
and 22 (3%) attended Meet and Greet (data on CME not available).some received a visit only (n = 87) and some received a
visit with an appreciation gift (n = 70). Four visits were
also made to large clinical practices in Bibb County and
the local health department.
Overall, 62% (n = 26) of providers who made referrals
(in some case multiple referrals) had either participated
in the focus groups, a CME session, “Meet and Greet”
event, or had received a visit. Seventy-four percent
(n = 65) of all patient referrals and 66% (n = 38) of clin-
ical evaluation patients were by providers who partici-
pated in an education or outreach activity of some type
(Table 4).
Clinical evaluation results
A total of 104 patients completed clinical evaluations, in-
cluding 5 adolescents (Table 5). On the basis of the 1994
case definition [5], 36% (n = 37) of patients had CFS, 17%
(n = 18) ISF, and 47% (n = 49) had an exclusionary medical
or psychiatric diagnosis. The sample was predominately
female (89%, n = 93), white (88%, n = 91), and well-
educated; 88% (n = 92) had a high school degree or above.
Mean age was 47.4 (SD = 14.6) (range 13 – 70), and mean
BMI was 27.2 (SD = 5.4). Forty-four percent (n = 46) of
those evaluated in the clinic were self-referred support
group members, and 58% (n = 57) (excluding adolescents)als and clinic evaluation1
# of referrals # of clinic evaluations
n (%) n (%)
10 (11) 5 (9)
4 (5) 3 (5)
7 (8) 3 (5)
12 (14) 6 (10)
31 (35) 20 (34)
1 (1) 1 (2)
23 (26) 20 (34)
88 58
pated in the focus group, 66 (8%) had incentive visit, 73 (9%) had visit only,
Table 5 Demographics of clinical sample by illness classification
CFS ISF Exclusion condition Total
n (%) n (%) n (%) n (%)
Sex
Female 33 (89) 13 (72) 47 (96) 93 (89)
Male 4 (11) 5 (28) 2 (4) 11 (11)
Age
Adolescent (<18) 1 (3) 3 (16) 1 (2) 5 (5)
18-20 0 0 3 (6) 3 (3)
21-30 3 (8) 3 (16) 2 (4) 8 (8)
31-40 9 (24) 3 (16) 5 (11) 17 (16)
41-50 6 (16) 1 (6) 8 (16) 15 (14)
51-60 12 (32) 6 (33) 19 (39) 37 (36)
61-70 6 (16) 2 (11) 11 (22) 19 (18)
Race
White 33 (89) 18 (100) 40 (82) 91 (88)
Black 3 (8) 0 7 (14) 10 (10)
Other 1 (3) 0 2 (4) 3 (3)
Education
1st through 8th grade 0 2 (11) 0 2 (2)
Some high school 3 (8) 2 (11) 5 (10) 10 (10)
High school graduate 5 (13) 1 (6) 8 (16) 14 (13)
Trade/Technical/Vocational after
High School 3 (8) 0 9 (18) 12 (12)
Some college 6 (16) 3 (17) 13 (27) 22 (21)
Two-year college graduate 6 (16) 4 (22) 5 (10) 15 (14)
Four-year college graduate 6 (16) 4 (22) 2 (4) 12 (12)
Postgraduate 6 (16) 2 (11) 5 (10) 13 (12)
Other 2 (5) 0 2 (4) 4 (4)
BMI
≤18 2 (5) 2 (11) 0 4 (4)
19-24 12 (32) 5 (26) 15 (31) 32 (31)
25-30 16 (43) 7 (58) 21 (43) 44 (42)
31-39 8 (22) 4 (21) 13 (27) 25 (24)
Previous CFS Diagnosisa
Yes 20 (54) 10 (56) 27 (56) 57 (55)
No 16 (43) 5 (28) 21 (44) 42 (40)
Total 37 18 49 104
aExcludes adolescent patients (n = 5).
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tion in this registry.
Of the 49 people classified as having an exclusionary
condition, the five most common exclusionary conditions
were hypothyroidism, diabetes, alcohol abuse, anemia,
and high levels of C-reactive protein (see Table 6 for a
complete list).Sixty-five percent (n = 24) of provider-referred patients
were CFS cases as compared to 35% (n = 13) of support
group referrals. Fifty-nine percent (n = 29) of support
group referrals had exclusionary conditions compared to
41% (n = 20) of provider-referred patients. Healthcare
providers referred 14 people (78%) who were classified
as ISF as compared to 4 (22%) support group referrals.






(n = 29) (n = 20)
Active inflammation 1 1
Alcohol abuse 4 –
Anemia 2 1
Anorexia bulimia – 1
Autoimmune disorder 1 –
Bipolar – 2
Cervical, thoracic, lumber spine
disease
– 1
Diabetes Type II/insulin resistance 7 1
Hepatitis C 1 –
High blood urea 2 –
High C-reactive protein (CRP)a,b 5 5
Hypertension 1 –
Hypothyroidism 7 3
Major depressive disorder with
melancholy
2 2
Mitochrondrial myopathy – 1
Obesity 2 –
Obstructive sleep apnea 1 1
Osteoarthritis 2 –
Narcolepsy 1 –
Restless leg syndrome 2 1
Rheumatoid arthritis 1 –
Sleep problems 1 –
Schizophrenia 1 –
Sickle cell – 1
Substance abuse – 3
Uncontrolled high blood pressure 1 –
Urinary tract infection 2 2
Total exclusion condition by
group
47 26
aPerson could have more than one exclusion condition and the exclusion
could be based on one or multiple conditions.
bAll persons with high CRP were excluded for other coexisting medical
conditions. While a high CRP value is not an exclusion as defined in the 1994
case definition, we identified persons with CRP values that were several fold
higher than the upper limits of normal values, as there may be an underlying
inflammatory, infectious, or cardiovascular disease.
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ral method; support group referrals had the lowest pro-
portion of patients classified as ISF but the highest
proportion of exclusions (x2 = 9.21, p < 0.05) (Table 7).
No significant association was found between history of
CFS diagnosis and illness classification. Clinical outcome
categories did not differ between the physician and non-
physician groups.Discussion
The pilot registry exceeded the recruitment goal of 600 by
registering 827 healthcare providers. Despite multiple
mailings, CME events and a registry website, telephone re-
cruitment was the most successful method for provider
registration, accounting for 94% of provider registration.
One reason that telephone recruitment worked well is that
healthcare providers could immediately respond to verifi-
cation questions upon receipt of the phone call. Focus
groups had suggested that a registry website would be de-
sirable for provider registration; nevertheless, only 2 of
827 providers registered through the site. However, enrol-
ling through the website, fax, or postal mail required a
two-step process: 1) filling out the Provider Verification
Form and 2) submitting the information. Given time con-
straints and other practice priorities, providers may have
been dissuaded to register through these channels.
Despite success in recruiting healthcare providers, only
42 (5%) of the 827 enrolled providers referred patients for
clinical evaluation, even though referral criteria were re-
laxed and based on fatiguing illnesses and not just CFS
(Table 1). Several explanations may account for this out-
come. First, healthcare providers were asked to refer pa-
tients that came into their offices during the study
enrollment period and not to look in medical charts for
referrals, thereby missing patients who met inclusion cri-
teria. Second, we opened registry registration to healthcare
providers of all specialties and not just to those who see or
treat people with fatigue. Many specialty providers may
not have had the opportunity for referral, as their patient
population would not be seeking care for fatigue.
Supporting this concept is the fact that none of the en-
rolled healthcare providers from anesthesiology, allergy
and immunology, infectious disease, rheumatology, endo-
crinology, gastroenterology, neurology, surgery, orthope-
dics, or ophthalmology made referrals, whereas primary
care providers (family practice and internal medicine) gen-
erated the greatest number of referrals (n = 33, 38%). This
finding also supports the view that many people with un-
explained fatiguing illnesses continue to seek healthcare
from their primary care providers. Finally, the firm hired
to recruit providers was compensated per enrolled provider
and therefore had an incentive to recruit and enroll as
many providers as possible, including providers who may
not have had an interest in chronic fatigue or the registry.
Of the 42 providers who made referrals, 62% received an
outreach visit or attended either a focus group, CME, or
“Meet and Greet” event. Of healthcare providers who re-
ceived education or outreach, three-quarters referred pa-
tients and two-thirds had patients complete the clinical
evaluation. Thus, education and active outreach to pro-
viders may have contributed to a greater number of patient
referrals and clinic evaluations as compared to no partici-
pation or providers who did not receive these initiatives.
Table 7 Illness classification by referral and previous CFS diagnosis n (%)
CFS ISF Exclusion condition
χ2
n = 37 n = 18 n = 49
Referral method
Provider 24 (65) 14 (78) 20 (41) 9.21*
Support group 13 (35) 4 (22) 29 (59)
Previous CFS Diagnosisa
Yes 20 (56) 10 (67) 27 (56) 7.25
No 16 (44) 5 (33) 21 (44)
*p < 0.05.
aExcludes adolescent patients (n = 5).
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“Meet and Greet”) to outreach activities (visits or visits
with incentives), outreach resulted in a higher number of
referrals (49%) and clinic evaluations (44%) compared to
education. Researchers interested in developing and oper-
ating a registry in which referrals are a goal may want to
consider incorporating visits to healthcare providers as one
technique to increase patient referral rates.
We opened registry enrollment to local support group
members. Although the self-referral process worked
well, with no complaints or confusion, only 28% of the
support group referred themselves for screening. Despite
the need for further research, results from this pilot
registry suggest that future CFS registries may want to
consider including enrollment directly from patient pop-
ulations if full clinical and laboratory exams are included
in a clinical assessment.
One-hundred and four patients were clinically evaluated
and, of these patients, 37 had CFS, 18 ISF, and 49 an ex-
clusionary condition. A little more than half of the sample
reported a previous CFS diagnosis, but this history was
equally distributed across illness classification conditions.
A relatively high proportion (47%) of the registry patients
had exclusionary conditions identified after clinical evalu-
ation. This finding replicates other CFS studies in which
50 - 70% of patients who met symptom criteria were
found to have medical or psychiatric exclusions [3,16,17].
Future research needs to examine the potential for
detecting treatable medical exclusionary conditions among
people suffering from fatiguing illnesses because treatment
may improve fatigue and associated symptoms for many
of these patients.
More revealing was the proportion (59%) of exclu-
sions found in the support group as compared to the
provider referred group. In fact, 63% of the support
group patients evaluated (29/46) had an exclusionary
condition identified. Despite awareness of their illness
(as evidenced by membership in support group), the
self-referral group had undetected medical conditions, and
some patients experienced more than one exclusionary
condition. For example, this group had seven cases ofdiabetes compared to one in the provider referral group,
and seven cases of hypothyroidism compared to three in
the provider group. In both groups, many of the exclu-
sionary conditions were detected on the screening labora-
tory tests and are treatable.
Forty-one percent of provider referrals were deter-
mined to have an exclusionary condition. Because pro-
viders were given a medical exclusion list and knew the
medical history of patients, one would expect lower
exclusion rates, e.g., few provider referrals resulting
in exclusions. Two possible explanations address this
phenomenon. First, most of the exclusions were identi-
fied on the basis of laboratory tests. Physician providers
were asked to give potential referrals by running basic
lab tests and completing a medical history; however, re-
ferrals could be made without the requirement for a
complete work-up, and laboratory testing may not have
been conducted. Lack of basic lab tests may have been
especially true for non-physician referrals, for which the
requirement was a medical history. Second, providers
may have welcomed participation in the registry as a
method to get assistance for diagnosing difficult or un-
known etiologies. Finally, the other main category of ex-
clusions for provider referrals were bipolar disorder,
major depressive disorder, substance abuse, and anorexia
bulimia, which is understandable as some of these diag-
noses are difficult to establish.
Sixty-five percent of provider-referred patients had CFS
compared to 35% of support group referrals. Sixty-five
percent of referred patients had CFS, which replicates
similar findings from the CFS Rochester Epidemiology
Project in which 66% of patients were accurately coded
into the CFS category [17]. For an illness that has no
known etiology or biomarkers, a fairly high level of know-
ledge and awareness was shown for providers who re-
ferred two-thirds of patients diagnosed with CFS at
clinical evaluation. Although further research is warranted,
part of the awareness may be due to the education and
outreach events in which 62% providers participated. The
main reason for not meeting CFS criteria was exclusionary
conditions as opposed to being classified as ISF. A higher
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fied as ISF as compared to support group patients (22%).
After exclusionary conditions are fully treated, those pa-
tients otherwise meeting criteria for CFS would be man-
aged in the same way as CFS.
We aimed to increase awareness and knowledge of
CFS among the healthcare community through several
education initiatives. CME events offered the opportun-
ity for professional credits and were offered through
local partnerships. We found from anecdotal feedback
that the newsletter, an item identified through the needs
assessment, was well-received and appreciated by pro-
viders. As community-based research has shown [18],
one of the most valuable aspects of this registry, which
contributed to its success, was the partnership with the
local medical society. The partnership allowed for educa-
tional outreach events with CME that would otherwise
have been time consuming and difficult to implement.
The partnership also gave registry staff access to the
healthcare community and enabled us to participate with
the community in building the registry.
This research has several limitations. The results re-
flect the experience of one study and future fatigue and
CFS registries may have different recommendations, as
registries have different study designs. The total number
of patients evaluated (104) is relatively small and the
pilot was conducted in one locality, so the findings may
not be generalizable. We did not have a way to deter-
mine the number of potentially eligible patients that
each provider saw during the time of the study. Because
this study was a pilot registry, we did not determine if
longitudinal information could be obtained.
While we did not exclude severely ill patients from
study participation, the study design made it difficult for
home-bound or other severely ill patients to participate
as they would need to travel to the local clinic for the
8-hour testing day. In fact, two referred patients can-
celed their clinical evaluations because they were not
feeling well enough to participate (Table 3). Researchers
may want to consider this aspect of participant recruit-
ment for future registries. Extra costs or other methodo-
logical issues may be incurred in arranging for testing at
a patient’s house, but this would allow for home-bound
and severely ill patients to be included in the registry.
Finally, depending on recruitment methods, cost and
sustainability of registries are an important aspect of fur-
ther research. For example, this study demonstrated that
in the Bibb County, Georgia area telephone recruitment
was the best method to enroll providers. We used several
different methods, for example, mailing materials and a
study website, before turning to telephone recruitment
even though focus group results indicated recruitment by
website was a preferred option. When developing future
registries, researchers may want to consider variousrecruitment methods in order to sustain enrollment. All
studies incur costs in the form of laboratory testing, med-
ical staff time, and data collection; study objectives should
be prioritized in terms of cost and sustainability.
In the needs assessment phase, providers had expressed
concerns about the 1996 Health Insurance Portability and
Accountability Act (HIPAA) procedures and the preference
for not being involved in the process of consenting pa-
tients. These concerns proved challenging in implementing
a system in which providers screened potential patients,
but the patients had to complete the referral process. From
the provider referrals, the registry staff could not contact
11% of patients for clinical assessment because 10 people
did not follow through by submitting permission-to-be-
contacted forms. This finding may also serve as a challenge
to other registries that rely on physician referrals or access
to medical records to confirm a diagnosis.
Conclusions
A pilot registry of unexplained fatigue and CFS in which
healthcare providers were registered to refer patients
suspected of having unexplained fatiguing illness or CFS
for a standardized clinical evaluation and diagnosis, pro-
vided information on clinicians’ accuracy in recognizing
aspects of fatiguing illness and CFS. It also identified
gaps in their knowledge, which may inform educational
initiatives and ultimately increase the number of people
receiving treatment. This pilot registry design allowed
many different types of healthcare providers to partici-
pate and permitted tracking of medical specialty in
terms of the referral process. The registry demonstrated
the feasibility of including both provider and support
group referrals. Results highlight the need and import-
ance for inclusion of thorough clinical and laboratory
exams in a CFS registry rather than relying on report of
a previous CFS diagnosis. Many exclusion conditions
were detected by laboratory tests and appeared to be
unknown to the participating patients and healthcare
providers. The number of untreated conditions in this
population also emphasizes the need for continued med-
ical follow-up to identify and manage conditions that
may develop, rather than attributing all illness symptoms
to CFS. Future CFS registries should consider how to
address exclusions when enrolling potential patients.
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